Biogen Reports First Quarter 2016 Revenues of $2.7 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Stifel Updates Ests on Biogen (BIIB) Following Q1 Report; Affirms at 'Hold'
April 21, 2016 12:36 PM EDTStifel affirms Biogen (Nasdaq: BIIB) at Hold following Q1 results issued earlier Thursday.
Analyst Thomas Shrader offered the following commentary: Biogen presented 1Q16 financial results today,... More
Biogen (BIIB) CEO Scangos Says Co. in Talks for 'Tuck-in' Deals, Later-Stage Assets - Conf. Call
April 21, 2016 8:55 AM EDTBiogen (NASDAQ: BIIB) CEO Scangos says the company is in talks for 'tuck in' deals and later-stage assets, according to commentary from the company's conference call on Thursday.
... MoreBiogen (BIIB) Tops Q1 EPS by 33c
April 21, 2016 7:16 AM EDTBiogen (NASDAQ: BIIB) reported Q1 EPS of $4.79, $0.33 better than the analyst estimate of $4.46. Revenue for the quarter came in at $2.73 billion versus the consensus estimate of $2.75 billion.
Growth was driven by a 15% increase in worldwide TECFIDERA revenues as well as... More
